Q-State Biosciences
Jonathan Thomas (“JT”) is the Chair of the Governing Board of the California Institute for Regenerative Medicine (CIRM), a public agency dedicated to advancing stem cell research and developing cures for people in need. As head of the board, JT is responsible for all aspects of CIRM’s $3 billion funding program. Before joining CIRM he was a Co-Founding Partner at Saybrook Capital, an investment banking and private equity firm, where he led an early round of financing for Advanced Cell Technology (now Ocata Therapeutics). JT’s legal experience includes clerking for White House Counsel Lloyd Cutler in the last year of the Carter Administration and clerking for the Honorable George Mackinnon of the United States Circuit Court of Appeals for the District of Columbia Circuit. JT holds a Bachelor’s degree from Yale University where he graduated summa cum laude, a J.D. from Yale, and a Ph.D. from Oxford University, where he was a George C. Marshall Scholar.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Q-State Biosciences
Q-State Biosciences is a technology-derived medicines company based in Cambridge, MA, that combines advanced human cellular models, unique measurement engineering, and AI/machine learning into a proprietary platform that enables novel discovery of optimized genetically targeted medicines for epilepsy, pain, and other diseases of the CNS.